Park, S.-S.; Shin, S.-H.; Lee, J.-Y.; Jeon, Y.-W.; Yhang, S.-A.; Min, C.-K.
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001). Cancers 2023, 15, 4783.
https://doi.org/10.3390/cancers15194783
AMA Style
Park S-S, Shin S-H, Lee J-Y, Jeon Y-W, Yhang S-A, Min C-K.
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001). Cancers. 2023; 15(19):4783.
https://doi.org/10.3390/cancers15194783
Chicago/Turabian Style
Park, Sung-Soo, Seung-Hwan Shin, Jung-Yeon Lee, Young-Woo Jeon, Seung-Ah Yhang, and Chang-Ki Min.
2023. "Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001)" Cancers 15, no. 19: 4783.
https://doi.org/10.3390/cancers15194783
APA Style
Park, S.-S., Shin, S.-H., Lee, J.-Y., Jeon, Y.-W., Yhang, S.-A., & Min, C.-K.
(2023). Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001). Cancers, 15(19), 4783.
https://doi.org/10.3390/cancers15194783
